Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2024-08-14 Major Shareholding Noti…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Major shareholder disclosure in Navamedic ASA
Major Shareholding Notification Classification · 98% confidence The document text is extremely short (137 characters) and explicitly states, "Major shareholder disclosure in Navamedic ASA" followed by instructions to "Please see attachment on www.newsweb.no". This structure indicates that the document itself is merely an announcement pointing to the actual disclosure document elsewhere. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement pointing to an attachment or external link should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is a specific type of disclosure (Major shareholder), and RNS is the general regulatory fallback, I will check if 'Major Shareholding Notification' (MRQ) fits. MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. This announcement directly relates to a major shareholder disclosure. Given the brevity and the nature of the content (a notification about a major shareholder change), MRQ is the most specific and appropriate classification, even though it is an announcement pointing elsewhere, as MRQ covers the notification itself.
2024-08-14 English
Major shareholder disclosure in Navamedic ASA
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Standard form for notification of major holdings" and contains structured fields detailing changes in voting rights, financial instruments, and shareholder information (e.g., Issuer: Navamedic ASA, Shareholder: Skandinaviska Enskilda Banken, Date: 2024-08-12). This format is characteristic of regulatory filings concerning significant changes in ownership thresholds. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2024-08-13 English
Major shareholder disclosure in Navamedic ASA
Major Shareholding Notification Classification · 98% confidence The document text is extremely short (137 characters) and explicitly states, "Major shareholder disclosure in Navamedic ASA" followed by instructions to "Please see attachment on www.newsweb.no". This structure indicates that the document itself is merely an announcement pointing to the actual disclosure document elsewhere. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement pointing to an attachment or external link should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is a specific type of disclosure (Major shareholder), and RNS is the general regulatory fallback, I will check if 'Major Shareholding Notification' (MRQ) fits. MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. This announcement directly relates to a major shareholder disclosure. Given the brevity and the nature of the content (a notification about a major shareholder change), MRQ is the most specific and appropriate classification, even though it is an announcement pointing elsewhere, as MRQ covers the notification itself.
2024-08-13 English
Navamedic ASA: Invitation to 2024 2nd quarter presentation
Report Publication Announcement Classification · 98% confidence The document is titled "Navamedic ASA: Invitation to 2024 2nd quarter presentation" and explicitly states that the company "will be presenting its 2nd quarter/1st half 2024 results on Friday, August 16, 2024." It provides details about the event (time, location) and mentions that a link to the webcast and presentation will be available on the investor relations website. Since this document is an announcement about the upcoming release/presentation of quarterly results, and not the results document itself, it fits the definition of a Report Publication Announcement (RPA). It is short and serves to announce the publication/event.
2024-08-12 English
Navamedic ASA - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text is structured as a formal notification detailing a transaction involving shares by a person discharging managerial responsibilities ('Primary insider: Sales and Marketing Director'). Specifically, it reports that Karianne Femtehjell Olsen 'Sold shares' on '12.07.2024' on the 'Oslo Stock Exchange'. This content directly matches the definition of a Director's Dealing report, which tracks personal share transactions by company directors and executives (insider trades). This corresponds to filing code DIRS.
2024-07-12 English
Navamedic ASA - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Navamedic ASA - Mandatory notification of trade' and explicitly states that a 'Primary insider' (Karianne Femtehjell Olsen) has sold shares. It details the transaction and references disclosure requirements under MAR Article 19, which governs insider trading notifications. This directly corresponds to the definition of Director's Dealing (DIRS). The document length is very short (727 chars), but it contains the core transaction details, making it the actual notification rather than just an announcement of a report.
2024-07-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.